Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
Mia Rosenblatt, Associate Director of Policy, Evidence and Influencing at Breast Cancer Now, said: “That half of women in England with potential...
10 February 2022
New research findings published in the New England Journal of Medicine, that found that pembrolizumab, if given in combination with chemotherapy...
10 February 2022
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It’s highly alarming that increasing numbers of women with potential breast...
7 February 2022
Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, who hosted the UK Interdisciplinary Breast Cancer Symposium...
31 January 2022
Dr Kotryna Temcinaite, Senior Research Communications Manager Breast Cancer Now, said: “Every year 55,000 UK women and 370 men are diagnosed with...
19 January 2022
The Scottish Medicines Consortium (SMC) has today announced its decision to recommend two new treatments – trastuzumab deruxtecan (Enhertu) and...
17 January 2022
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “It’s highly alarming that record numbers of women with potential breast...
13 January 2022
Dr Simon Vincent, Director of Research, Support and Influencing at Breast Cancer Now, said: “People who have inherited an altered gene will...
11 January 2022
Baroness Delyth Morgan, Chief Executive at Breast Cancer Now, said: “We fully support current efforts to roll out COVID-19 booster jabs by the end...
13 December 2021